Tag Archives: Patients

FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis

FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis Print this page Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically… Read More »

Flying cross country amid coronavirus pandemic for heart surgery: One patient’s success story

Jeffrey Street’s unruptured aortic aneurysm was stretching his aortic valve with severe leakage. A life-saving surgery awaited him in New York City, but that required a cross-country flight amid the coronavirus pandemic. “When we operated on him we actually saw a little tear in the aorta right where the aneurysm was. … I mean, you can’t… Read More »